HOME >> BIOLOGY >> NEWS
Common gene variant increases risk of atherosclerosis

A common version of a gene has been identified as a potent risk factor for early-onset atherosclerosis, report the Johns Hopkins scientists who first linked it to shorter life expectancy in humans. Their report appears in the May issue of the American Journal of Human Genetics.

Using information and samples from two earlier studies of people at high risk for heart disease, the team discovered that those with at least one copy of a specific version of this gene, called "klotho," are almost twice as likely to have undetected atherosclerosis than others. Startlingly, smokers with low amounts of "good" cholesterol had 10-fold greater risk if they also had this gene variant.

"If you knew you had this version of klotho, should you keep smoking? Should you exercise more? Eat better? Lose weight?" asks Hal Dietz, M.D., a Howard Hughes Medical Institute associate investigator and professor of pediatrics and molecular biology and genetics at Johns Hopkins. "This gene variant appears to be a potent risk factor for atherosclerosis.

"You have to be very careful with association-type studies like ours, but what we've seen here is not a subtle trend but a strong observation in two independent study populations," adds Dietz, also a member of Hopkins' McKusick-Nathans Institute for Genetic Medicine.

Atherosclerosis, or so-called hardening of the arteries, is a key risk factor for heart attack and stroke, two of the nation's top killers. Lifestyle changes, such as eating a healthier diet, quitting smoking, exercising more and taking certain drugs, can lower the risk of heart disease and death by reducing cholesterol levels and weight.

Everyone has two copies of the klotho gene (one inherited from each parent), but last year the Hopkins researchers found that, of several common versions of klotho, one was associated with earlier death from all causes. Moreover, they showed that roughly 2.5 percent of the population has two copies of this "bad"
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
1-May-2003


Page: 1 2 3

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common thyroid cancer gene mutation found

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... 01, 2020 , ... Catalent, a global leader in clinical ... packaging facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating ... the new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving ...
(Date:6/28/2020)... JUPITER, Fla. (PRWEB) , ... June 25, 2020 , ... ... will focus on innovations in accelerated Point of Care Testing solutions (POCT). Check local ... labs. Samples are collected at medical offices and are shipped to labs throughout the ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable ... testing operations in the fight against the COVID-19 pandemic in Zambia. , One ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... N.J (PRWEB) , ... July 29, 2020 , ... ... company, and Catalent, the leading global provider of advanced delivery technologies, development, and ... today announced that they have entered into a strategic partnership whereby Catalent will ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and ... a great surgery is only the beginning of a successful study, while protecting and ... Join Brad Gien, Global Head of Surgery from Envigo in a ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... today that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive ... PathSensors to move into the point-of-care diagnostic market, focusing initially on the ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a ... 2020, despite many obstacles created as a result of COVID-19. As a provider ... partnered medical practices and medical manufacturers by expanding access to device offerings, technology ...
Breaking Biology Technology:
Cached News: